Interestingly, Cheng et al. revealed that hepatitis B (HBV) or HBx upregulates SIRT2 expression by targeting its promoter, which then enhanced transformation of HBV-related HCC (53). Here, SIRT2 is linked to hepatocellular carcinoma.